Global Biosimilar Market - Opportunities & Forecast, 2020-2027
GMI Research market report focuses on
providing an overview of the industry through detailed market segmentation. The
report has information related to the overview and scope of the market followed
by the key drivers, restraints, and emerging trends in the market. This report
is especially designed to include both qualitative and quantitative aspects of
the industry in each region and country included in the study.
List of Significant Manufacturers in the
Biosimilar Market include:
·
Amgen Inc.
·
Novartis AG
·
Dr. Reddy’s Laboratories Ltd.
·
F. Hoffmann-La Roche Ltd.
·
Mylan N.V.
·
Sandoz International GmbH
·
Teva Pharmaceutical Industries
Ltd.
·
Pfizer Inc.
·
Samsung Bioepis
·
LG Life Sciences
·
Biocon
Biosimilar Market Drivers and
Restraints:
Biosimilar is majorly applied in medical,
healthcare sectors, pharmaceuticals, and biotechnology. The primary factor
boosting the growth of the biosimilar
market includes cost-effectiveness, which is less than its original
clinical product. Cost-effectiveness enables us to drive uptake of the
biosimilar market by growing treatment. Its individual brand name identifies
every biosimilar product, and it will vary from other biosimilar products.
After the original product's expiration, there is a wide opportunity for a
generic version of the biosimilar market.
Biosimilar product is highly targeting to monoclonal antibodies (MAbs)
development. Other important segments of this market, such as erythropoietin,
human growth hormone, interferon, insulin. Biosimilar products are extremely
sensitive to manufacturing changes. On the other hand, one of the potential
threats of a biosimilar product is an antigen, and immunogenicity, to provoke
the immunity of the human body.
Segmentation: Biosimilar Market
Biosimilar Market: By Types of Product
·
Human Growth Hormone
·
Granulocyte Colony-stimulating
Factor (G-CSF)
·
Insulin
·
Interferon
·
Erythropoietin
·
Immunomodulators
·
Monoclonal antibodies
Biosimilar Market: By Application Type
·
Blood Disorders
·
Oncology
·
Growth Hormonal Deficiency
·
Chronic and Autoimmune Disease
·
Endocrinology
·
Nephrology
Biosimilar Market: By Region
·
North America
o
United States of America
o
Canada
·
Asia Pacific
o
China
o
Japan
o
India
o
Rest of APAC
·
Europe
o
United Kingdom
o
Germany
o
France
o
Spain
o
Rest of Europe
·
RoW
o
Brazil
o
South Africa
o
Saudi Arabia
o
UAE
o
Rest of the world (remaining
countries of the LAMEA region)
About GMI Research
Our
in-depth market reports help propel your business with all the data, strategic
inputs, and competitive intelligence to move ahead even in the most uncertain
times. Featured in the ‘Top 20 Most Promising Market Research Consultants’
list of Silicon India Magazine in 2018, we at GMI Research look forward to help
businesses stay ahead of the curve.
Comments